The Patent Finder

Pierce Biotechnology, Inc.

18 patents currently held · Updated Nov 16, 2026
45 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Jul 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jun 8, 2027
    The maintenance fee for Modified nucleotides methods and kits (US 9,206,216) comes due Jun 8, 2027. Unpaid by Dec 8, 2027, it lapses early.
  • 2 fees due Aug 2, 2027
  • 1 fee due Sep 22, 2027
    The maintenance fee for Electroblot transfer buffer (US 9,291,596) comes due Sep 22, 2027. Unpaid by Mar 22, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 7,960,519Extraction of cellular components with fatty acid derivatives
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,007,998Polymerized conjugates for biological applications
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,745,153Pyrocatechol violet-metal protein assay
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,507,291Detergent removal from protein samples prior to mass spectrometry analysis
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,828,633Modified nucleotides methods and kits
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,572,507Systems and methods for interacting with dynamic protocols
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,536,323Modified nucleotides
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,945,861Methods for isotopically labeling biomolecules using mammalian cell-free extracts
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,206,216Modified nucleotides methods and kits
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,248,407Dialysis Device
In force
 · High confidence
In forceHigh confidence
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
Also on record, not counted in the 18: 45 patents in force now held by others · 1 lapsed for an unpaid fee · 37 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

10 pending · 3 abandoned · 15 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited